Skip to main content

stock

IMNN · Imunon, Inc.

What Imunon, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live IMNN price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on IMNN.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
5,611,403 as of 2026-08-10 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
340.8%
ROA
95.2%

Health

Current ratio
1.8x
Debt/equity
—

Deep value

NCAV
-$2.11M
NCAV per share
-$0.38
Price/NCAV
Locked
NNWC
-$3.94M
NNWC per share
-$0.70
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30——Gross profit: unreported by this company.-$2.79M-$2.81M
10-Q filed 2026-08-11
2026-03-31——Gross profit: unreported by this company.-$4.31M-$4.25M
10-Q filed 2026-05-12
2025-12-31——Gross profit: unreported by this company.-$4.26M$24.77M
DEF 14A filed 2026-05-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——Gross profit: unreported by this company.-$3.48M-$3.43M
10-Q filed 2025-11-13
2025-06-30——Gross profit: unreported by this company.-$2.77M-$2.74M
10-Q filed 2026-08-11
2025-03-31——Gross profit: unreported by this company.-$4.15M-$4.10M
10-Q filed 2026-05-12
2024-12-31——Gross profit: unreported by this company.-$4.15M-$4.06M
DEF 14A filed 2026-05-04
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——Gross profit: unreported by this company.-$4.96M-$4.85M
10-Q filed 2025-11-13
Assets
$14.99M
Equity
$4.19M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31—-$14.65M$14.50M-$14.18M
2024-12-31—-$19.13M-$18.62M-$18.88M
2023-12-31—-$21.03M-$19.51M-$19.47M
2022-12-31$500,000-$24.92M-$35.90M-$23.36M
2021-12-31$500,000-$21.01M-$20.77M-$16.54M
2020-12-31$500,000-$18.49M-$21.48M-$15.64M
2019-12-31$500,000-$20.57M-$16.85M-$20.61M
2018-12-31$500,000-$21.07M-$11.88M-$7.18M
2017-12-31$500,000-$18.47M-$20.40M-$16.68M
2016-12-31—-$20.65M-$22.05M-$18.44M

Company filings

2 offering filings in 12 months · since Mon Mar 23

events

  • Material agreement, Unregistered share sale, Bylaws or fiscal year change

    Material agreementUnregistered share saleBylaws or fiscal year change
    Sep 298-K
  • Executive or director change

    Executive or director change
    Aug 118-K
  • Results

    Results
    Aug 118-K
  • Executive or director change

    Executive or director change
    Jun 308-K
  • Executive or director change, Shareholder vote results

    Executive or director changeShareholder vote results
    Jun 168-K
  • Material agreement, New debt, Unregistered share sale, Bylaws or fiscal year change, Regulation FD disclosure

    Material agreementNew debtUnregistered share saleBylaws or fiscal year changeRegulation FD disclosure
    Jun 48-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Eylward Susan

    General Counsel and Corp Sec

    Sale$3,950

    Sep 1, 4:06 PM ET

  • Eylward Susan

    General Counsel and Corp Sec

    Sale$3,993

    Aug 17, 4:17 PM ET

  • Eylward Susan

    General Counsel and Corp Sec

    Sale$3,977

    Aug 4, 4:13 PM ET

  • Eylward Susan

    General Counsel and Corp Sec

    Sale$3,830

    Jul 21, 4:15 PM ET

All insider trades for IMNN

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named IMNN, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about IMNN.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about IMNN.

nakagai

Signals on IMNN come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the IMNN board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Imunon, Inc. (IMNN): SEC filings, financials and insider trades · Nakagai